Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.520
-0.030 (-1.94%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $430.56 million as of March 28, 2025. Its market cap has increased by 28.81% in one year.
Market Cap
430.56M
Enterprise Value
41.98M
1-Year Change
28.81%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $430.56M, a decrease of -76.83%. That is a compound annual growth rate of -32.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 430.56M | -39.33% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |